Old Web
English
Sign In
Acemap
>
authorDetail
>
Volk Michael A
Volk Michael A
Sepsis
Antioxidant
Medicine
Internal medicine
Gastroenterology
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prophylactic administration of a clinically safe low dose of the COVID-19 drug candidate Rejuveinix (RJX) effectively prevents fatal cytokine storm and mitigates inflammatory organ injury in a mouse model of sepsis
2021
Clinical investigation
Fatih M. Uckun
Cemal Orhan
Ibrahim Hanifi Ozercan
Nurhan Sahin
Joy Powell
Natalie Pizzimenti
Volk Michael A
Kazım Şahin
Show All
Source
Cite
Save
Citations (0)
Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix
2021
bioRxiv
Fatih M. Uckun
Cemal Orhan
Joy Powell
Emre Sahin
Ibrahim Hanifi Ozercan
Volk Michael A
Kazım Şahin
Show All
Source
Cite
Save
Citations (0)
Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix (RJX).
2021
Biomedicine & Pharmacotherapy
Fatih M. Uckun
Cemal Orhan
Joy Powell
Emre Sahin
Ibrahim Hanifi Ozercan
Volk Michael A
Kazım Şahin
Show All
Source
Cite
Save
Citations (0)
Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders
2021
bioRxiv
Fatih M. Uckun
Mehmet Tuzcu
Marcus Gitterle
Volk Michael A
Kazım Şahin
Show All
Source
Cite
Save
Citations (0)
1